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Diarrhea, malabsorption, and weight loss, enteropathic 
manifestations of HIV type 1 (HIV-1) [1–4], and simian im-
munodeficiency virus (SIV) infections [5–7] are usually the 
result of concurrent infection by other viruses, bacteria, 
and protozoa in the later stages of infection. However, both 
HIV-1 [8] and SIV can themselves, in the absence of other 
enteric pathogens, cause malabsorption and histopatholgi-
cal changes in the gut that are detectable as early as the end 
of the second week of SIV infection [6, 7]. The underlying 
mechanism of these earlystage-HIV and -SIV enteropathies 
are unknown, but the increased expression of cell-cycle 
genes [9, 10] and pathological changes of regenerative vil-
lous atrophy [5, 7, 11] point to infection-induced increases 
in turnover of gut epithelium.
We sought the antecedent causes of the enteropa-
thy and increased turnover of gut epithelium in tissues 
collected in the course of published studies [12] of the 
SIVnonhuman- primate (rhesus macaque) model of HIV-1 
vaginal transmission and early infection. We reasoned that 
these tissues might provide an opportunity to discover vi-
rus-induced mechanisms of increased turnover and enterop-
athy in the time frame when they might be the most appar-
ent, between 7 days postinoculation (dpi) and 10–14 dpi. The 
former is the time infection had disseminated from the vag-
inal site of inoculation to gutassociated and other lymphatic 
tissues, whereas the latter is the peak period of viral replica-
tion in the gut and throughout the lymphatic tissues and the 
time at which evidence of increased turnover of gut epithe-
lium had been previously documented [7, 9–11]. We now re-
port that, within this short period, there is massive apoptosis 
and an associated increase in proliferation of gut epithelium, 
which identify apoptosis of gut epithelium as the underly-
ing mechanism of the regenerative villous atrophy that char-
acterizes the gut pathology of early infection.
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Abstract
The enteropathic manifestations of the human immunodeficiency virus (HIV) and the simian immunodefi-
ciency virus (SIV) in late infection are usually due to infection by other microbes, but in early infection the vi-
ruses themselves cause an enteropathy by heretofore undetermined mechanisms. Here we report that SIV in-
duces massive apoptosis of intestinal epithelial cells lining the small and large bowel, thus identifying apoptosis 
as the driving force behind the regenerative pathology of early infection. We found that apoptosis of gut epi-
thelium paralleled the previously documented apoptosis and massive depletion of CD4 T cells in gut lamina 
propria, triggered by established mechanisms of gut epithelial cell apoptosis and, at peak, possibly by virus in-
teractions with GPR15/Bob, an intestinal epithelial cell–associated alternative coreceptor for SIV and HIV-1. 
Apoptosis in early SIV infection is thus the common theme of the pathological processes that quickly afflict the 
innate as well as adaptive arms of the gut immune system.
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Materials and Methods
Gut tissues from SIV-infected animals. Colon and small-
bowel tissues were obtained at necropsy 1–28 days after 
adult female rhesus macaques (Macacca mulatta) had been 
inoculated intravaginally twice the same day with 1 × 105 
of 50% tissueculture infectious dose of either SIVmac251 or 
SIVmac239, as described by Miller et al. [12] and summa-
rized in table 1. Tissues were fixed in paraformaldehyde or 
Streck’s Tissue Fixative before being embedded in paraffin.
Immunohistochemistry. Tissue sections (5–8 µm) fixed 
in either paraformaldehyde or Streck’s Tissue Fixative 
were rehydrated in deionized distilled water and blocked 
for endogenous peroxidase activity by being immersed 
in 3% H2O2 in methanol for 30 min. For antigen retrieval, 
slides were incubated in either citrate buffer (10 mmol/L, 
pH 6.0), EDTA (1 mmol/L, pH 8.0), EDTA Decloaker (Bio-
care Medical), or Reveal buffer (Biocare Medical) for 20 
min at 95°C–98°C, and, after cooling for 20 min, the slides 
were immersed in 3% normal serum in TNB (TNB block-
ing buffer, 0.1 mol/L Tris-HCl, pH 7.5; 0.15 mol/L NaCl; 
0.5% blocking reagent [Dupont]) for 30 min and in BACK-
GROUND SNIPER (Biocare Medical) for 10 min–1 h. The 
sections were then incubated overnight at 4°C in a humid-
ified chamber with primary antibodies (table 2) diluted in 
either 10% BACKGROUND SNIPER or, as a negative con-
trol, isotype control immunoglobulin. After being rinsed, 
the sections were developed by staining, according to the 
manufacturer’s instructions, in one of the following sys-
tems: biotin-free mouse DakoCytomation EnVision+ Sys-
tem-HRP (Dako), MACH-3 mouse–horseradish peroxidase 
(HRP) polymer (Biocare Medical), MACH-3 rabbit-probe 
HRP polymer (Biocare Medical), MACH-3 mouse-probe 
alkaline phosphatase polymer (Biocare Medical) and HRP 
substrate diaminobenzidine (DAB), or alkaline-phospha-
tase substrate Vulcan Fast Red (Biocare Medical). The sec-
tions were then counterstained with hematoxylin (Biocare 
Medical), for the Fast Red substrate, and Harris hematox-
ylin (Surgipath Medical), for the DAB substrate. All immu-
nohistochemical (and immunofluorescent) staining was 
shown to be specific, on the basis of the lack of staining 
with the isotype control. For the antibodies used, sources, 
dilutions, and other details, see table 2.
Immunofluorescence and confocal microscopy. As has 
been described by Li et al. [13], sections were stained with 
primary antibodies overnight at 4°C, were washed in PBS-
Tween20 (0.05% v/v), and incubated, for 1 h at room tem-
perature, with donkey secondary antibodies with mini-
mal cross-reactivity that were conjugated with Alexa 488 
(green) or 555 (red). Cell nuclei were counterstained blue 
withTOTO-3.ABio-RadMRC1000 confocal microscope was 
used to collect, at wavelengths specific for each fluoro-
phore, confocal images at 600× or 1200× magnification, by 
acquiring, at every time point analyzed, the brightest point 
projection from at least 12–18 randomly selected regions 
of the small and large bowel. For every image collected, 
each fluorescence channel was sequentially acquired, bi-
nary images were imported into Adobe Photoshop CS Pho-
toshop, were converted into red/green/blue color images, 
and were merged to generate either dual- or triple-labeled 
images. To allow better visualization of the GPR15/Bob 
receptor translocation and alterations, some images not 
showing nuclear staining are also shown.
In situ hybridization. SIV RNA was detected, by in situ 
hybridization, in paraformaldehyde-fixed and paraffin-em-
bedded tissues, as described by Li et al. [13]. In brief, 6–8 
µm sections were cut and adhered to slides treated with 
3-aminopropyltrioxysilane. After deparaffinization in xy-
lene, rehydration in PBS, and permeabilization by treating 
the sections with HCl, digitonin, and proteinase K, the sec-
tions were acetylated and hybridized to 35S-labeled SIVspe-
cific riboprobes. After being washed and digested with ri-
bonucleases, the sections were coated with nuclear-track 
emulsion, were exposed and developed, and were counter-
stained with Wright.
Quantification of gut epithelial cell apoptosis and pro-
liferation. We quantified apoptosis and proliferation by us-
ing an approach similar to that described by Holubec et al. 
[14]. Images of colon tissue immunohistochemically stained 
to detect cleaved cytokeratin 18 or Ki67 and counterstained 
with hematoxylin were randomly captured by use of Scion 
visiCapture software (version 1.3) and an Olympus BX60 
microscope (20x/numeric aperture 0.70) coupled with a 
Scion Color IEEE-1394 Camera (Scion). Cleaved CK18+ gut 
epithelial cells and total gut epithelial nuclei in 30 fields 
at 200× magnification were enumerated manually and in-
dependently by 2 investigators using Adobe Photoshop 
CS2. Apoptosis was expressed as the mean percentage of 
cleaved CK18+ cells and nuclei counted. Colonic proliferat-
ing Ki67+ cells were similarly quantified in crypts, in which 
the bases, middle portions, and tops were in the same fo-
cal plane.
Table 2. Details on antibodies used. The table is available 
following page 429.
Table 1. Information on the animals and status of tissues.
           Gut lamina propria  
 Cervical/                 CD4 T cells  
Day(s)  vaginal   Gut 
postinoculationa  infection  infection  Depletion Apoptosis
0, 2 – – – –
4 + – – –
7, 8 + + + 3+
13, 14 + 3+ 3+ ±
21 + 2+ 3+ ±
28 ± + 3+ ±
Key: –, not detected; +, detected on scale of 1–3; ±, detected at low 
frequency. Data are from Miller et al. [12] and Li et al. [13].
a. Infection of tissues was determined by detection of simian immuno-
deficiency virus RNA+ cells, by in situ hybridization.
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Figure 1. Apoptosis of gut epithelial cells and lamina propria cells in small and large bowel, in early simian immunodeficiency vi-
rus infection. Activated caspase-3 as a marker of apoptosis was detected immunohistochemically by use of Vulcan Fast Red sub-
strate. In panel A, the larger arrow indicates one of several red-stained apoptotic gut epithelial cells lining a cross-section of jejunal 
villi at the onset of viral replication in gut, and the smaller arrow indicates one of many red-stained activated caspase-3+ apoptotic 
cells in the lamina propria, which elsewhere have been shown to be effector memory CD4+ T cells [13]. The inset shows the negli-
gible staining in a section of jejunum from an uninfected animal. Original magnification, ×200. In panel B, the large arrow indicates 
one of several apoptotic gut epithelial cells lining the colon, and the small arrow indicates apoptotic lamina propria cells at the on-
set of viral replication in gut. Original magnification, ×400.
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Statistical tests. To examine the overall effect, at various 
weeks postinfection, on the levels of cytokeratin 18 and 
Ki67, we fit an analysis-of-variance model and used the F 
statistic to test for an effect of time (with weeks postinfec-
tion being treated as a factor). This method allows us to in-
vestigate the effect of time without having to assume some 
form for the relationship (such as linear) between levels 
and time. To then test for differences between baseline lev-
els and those at specific days, we used the 2-sample t test 
(with equal variances). To control the overall significance 
level for each response of interest, a Bonferonni adjustment 
was used for these t tests.
Results
Gut epithelial cell apoptosis in early SIV infection. 
Elsewhere, we already had shown that, at 7–14 dpi, there 
was massive depletion of memory CD4+ T cells and that 
this coincided with commensurate increases in apoptosis 
of lamina propriaCD4+ T cells [13], as is illustrated, in fig-
ure 1, by the large number of activated caspase 3+ cells in 
small-bowel lamina propria at 8 dpi, a result supporting 
our previously reported conclusion [13] that apoptosis of 
CD4+ T cells contributed significantly to CD4+ T cell deple-
tion in the gut. However, as is evident in figure 1, we also 
observed focal increases in activated caspase-3+ apoptotic 
gut epithelial cells in both the small and large bowel (figure 
1Aand 1B), which suggested a new hypothesis: apoptosis 
of gut epithelium is the mechanism underlying the regen-
erative enteropathy of early infection.
To test this hypothesis, we quantified apoptosis of gut 
epithelium over the course of early infection, with the 
same tissues and time frame that we had used to docu-
ment apoptosis of lamina propria CD4+ T cells (table 1 and 
[12, 13]). As predicted by the hypothesis, we found large 
increases in activated caspase 3+ gut epithelium lining the 
small and large bowel. Increased apoptosis was detectable 
in the exponential phase (7 dpi) of viral replication in the 
Figure 2. Time course of increased gut epithelial cell apoptosis in the large bowel. A–C, Apoptotic epithelial cells stained red with 
antibodies to cleaved cytokeratin 18, a specific marker for epithelial cell apoptosis, and Vulcan Fast Red substrate. Note the in-
creasing number of red-staining apoptotic cells lining the bowel, in an uninfected animal (A) and in an animal at the onset (B) and 
peak (C) of gut infection. Original magnifications, ×200. D, Percentage of apoptotic gut epithelial cells in large bowel, determined 
as described in Materials and Methods, in 2 animals per time point, for the indicated days after intravaginal inoculation. Days 0 
and 2 (0–2) are, respectively, before inoculation and before spread of infection to gut; days 7 and 8 are the initial phase of gut in-
fection, days 13 and 14 are the broad peak of replication, and days 20, 21, and 28 are the decline phase, in return to set-point lev-
els. Error bars indicate SEs.
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gut, peaked at day 14 dpi, in parallel with peak viral repli-
cation, and then decreased by 28 dpi, the last time point ex-
amined in these studies [12]. We confirmed the activated 
caspase-3 results by using antibodies to cleaved cytoker-
atin 18, a specific marker for epithelial cell apoptosis [14], 
in colon-tissue sections stained with this antibody. Figure 
2A–2C shows the increases in apoptosis of gut epithelium 
at 7 and 14 dpi, compared with apoptosis in an uninfected 
animal. We quantified the changes by using this marker in 
apoptotic epithelial cells in the colons (figure 2D) of 2 ani-
mals before detection of SIV-infected cells in the gut (i.e., at 
0–2 dpi) and in 8 animals after gut infection (2 animals each 
in the exponential, peak, and decline phases [2 animals at 
days 20/21 and 2 animals at day 28] of viral replication in 
the gut tissues) [13]. The percentage of apoptotic epithelial 
cells lining the colon at 7–8 dpi was 15-fold higher than ei-
ther that in an uninfected animal or that in an infected an-
imal before gut infection, was 30-fold higher at the peak 
(i.e., at 14 dpi), and was still 8-fold higher at 28 dpi. There 
was remarkably little interanimal variation (note that the 
SEs for animals examined 1 or 2 days apart were small), 
which attested to the reproducibility of the process, and all 
the increases were highly statistically significant: P = 5.6 × 
10–6 overall and P = .004 when the percentage before infec-
tion of gut was compared with that at 28 dpi.
Gut epithelial cell proliferation and gut pathology in 
early SIV infection. These increases suggested that, to 
maintain mucosal integrity, gut epithelial cell apoptosis 
might drive a compensatory increase in proliferation, as 
an exaggeration of a normal homeostatic mechanism in the 
gut, in which the integrity of the mucosal barrier is main-
tained by balancing the loss of apoptotic epithelial cells at 
the tops of the crypts by replacement through division of 
stem cells at the bases of the crypts [15]. We indeed doc-
umented increases in proliferation of gut epithelium that 
are consistent with a compensatory response to increased 
apoptosis. Using Ki67 as a marker for cell proliferation, we 
detected increased numbers of Ki67+ gut epithelial cells, 
and they continued to increase in parallel with gut epithe-
lial apoptosis, peaking at highly significant (P > .001) lev-
els, >3-fold higher than either those in an uninfected ani-
mal or those in an infected animal before gut infection. In 
Figure 3. Increased proliferation of gut epithelial cells. Cycling cells were detected immunohistochemically by use of antibodies to 
Ki67 and Vulcan Fast Red substrate. Sections were counterstained blue with Biocare hematoxylin. Before gut infection (day 0) (A), 
most of the red-stained proliferating Ki67+ gut epithelial cells are either close to the base of the colonic crypts (encircled) or extend 
only a short way toward the top (short arrow). At peak replication and gut epithelial cell apoptosis (B), increased numbers of Ki67+ 
gut epithelial cells extend from the base to nearly the tops of the crypts (long arrow). Original magnification, ×200. C, Percentage 
of colonic Ki67+ gut epithelial cells, determined as described in Materials and Methods, in animals at the time points shown, corre-
sponding to animals described in figure 2. Increased proliferation was detectable at 7 days postinoculation (dpi), peaked at 14 dpi, 
and remained elevated at 28 dpi, the last time point of examination. Arrows point to the corresponding images in panels A and B.
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addition, the Ki67+ gut epithelial cells were not confined to 
the bases but extended to the tops of the colonic crypts (fig-
ure 3A–3C).
The increased proliferation was associated with 
the histopathological changes in acute SIV infection of 
regenerative villous atrophy in the small bowel that have 
been described elsewhere [5, 7, 11]. Villous atrophy was al-
ready detectable at the second week of infection but was 
most prominent at 28 dpi (figure 4A– 4C); at that time, 
there was additional evidence of pathology in 1 animal in 
which we found multiple microabscesses with neutrophilic 
infiltrates (figure 4C).
Gut epithelial cell apoptosis: possible mechanisms. We 
investigated 4 mechanisms by which SIV infection and as-
sociated immune activation might induce gut epithelial 
cell apoptosis. First, we found that productive infection of 
gut epithelial cells is not likely to be the mechanism, be-
cause the only cells in which we detected SIVRNAby in 
situ hybridization were mononuclear cells (MNCs) in the 
lamina propria and lymphoid follicles (figure 5A), cells 
that we had elsewhere shown to be memory CD4+ T cells 
[13]. Second, because increased expression of Fas in en-
terocytes and Fas-L by intraepithelial or lamina propria 
lymphocytes can induce gut epithelial cell apoptosis [16, 
17], we assessed Fas and Fas-L expression and found that, 
at the onset of increased gut epithelial cell apoptosis, there 
was a correlation between focal increases in expression of 
Fas in enterocytes and lamina propria lymphocytes (figure 
5B) and Fas-L expression in lamina propria lymphocytes 
(figure 5C), a correlation that is consistent with this second 
mechanism. However, such a mechanism could not ac-
count for the peak of gut epithelial cell apoptosis at 14 dpi, 
because, by that time, Fas-L+ lamina propria lymphocytes 
had been largely depleted and Fas+ gut epithelial cells 
were no longer detectable (not shown). Third, because 
proinflammatory cytokine tumor-necrosis factor (TNF)–α 
and interferon (IFN)–γ induce gut epithelial cell apoptosis 
in vitro [18, 19], we investigated their expression.Wefound 
that, at the onset of increased gut epithelial cell apopto-
sis, there were also increased numbers of cells positive for 
TNF-α (figure 5D) and IFN-γ (not shown), findings that 
are consistent with both a contribution to the initial in-
creases in gut epithelial cell apoptosis and the previously 
documented increased expression of IFN-γ and TNF-α 
mRNA in gut and other tissues from these animals [20]. 
However, again, at the peak of gut epithelial cell apopto-
sis, we did not detect TNF-α+ cells by immunohistochem-
ical staining (figure 5E), a result that is consistent with the 
results of analyses of cytokinemRNAlevels in these ani-
mals, in which peak gut epithelial cell apoptosis occurs 
at a time when TNF-α and IFN-γ mRNAs have been re-
ported to be at their lowest level in the gut [20]. Thus, es-
tablished mechanisms of gut epithelial apoptosis may play 
a role in the initial increases in gut epithelial cell apoptosis 
but cannot account for its peak level.
Gut epithelial cell apoptosis coincides with viral de-
position at the basal surfaces of gut epithelial cells, and 
transcytosis and shedding of GPR15/Bob. Peak gut epithe-
lial cell apoptosis coincided with visible interactions be-
tween virus and GPR15/ Bob, an alternative coreceptor for 
SIV [21] and HIV [22] and a mediator of CD4-independent 
Figure 4. Gut pathology. Sections of jejunum stained with he-
matoxylin and eosin, from animals before (A) and 28 dpi (B) in-
fection, showing the shortened villi. C, 2 microabscesses with 
neutrophilic infiltrates (arrows) in large bowel at 28 dpi. Origi-
nal magnifications, ×100.
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entry [23] that has been found to be implicated in HIV en-
teropathy [24, 25]. Before and at the onset of gut infection 
in the animals, we detected only background levels of vi-
ral RNA in a particulate pattern characteristic of virions de-
posited along the basal surfaces of gut epithelium (figure 
6A), and GPR15/Bob was mainly detectable at the basal 
surfaces of gut epithelium, to a lesser extent at apical sur-
faces, and in MNCs in lamina propria of the small and 
large bowel (figure 6B and 6C), just as has been described 
as occurring in human gut tissues [24]. However, at the 
peak of gut epithelial cell apoptosis, we observed a striking 
pattern of virion binding to the basal surfaces of gut epithe-
lium in the large bowel (figure 6D and 6E) and small bowel 
(figure 6F), which coincided with a previously undescribed 
and remarkable transcytosis and shedding of GPR15/ Bob 
into the intestinal lumen (figure 6G and 6H). By 28 dpi, 
there were concordant decreases in gut epithelial cell apop-
tosis, luminal shedding of GPR15/Bob, and increased ex-
pression of the latter at the basal and apical surfaces of gut 
epithelium (figure 6I).
Discussion
The principal finding that we have reported here—that is, 
massive gut epithelial cell apoptosis—now provides both 
a mechanism for the regenerative enteropathy of early SIV 
infection and an explanation for the increased expression 
of cell-cycle genes that elsewhere have been documented in 
microarray studies of SIV enteropathy [9, 10]. Although the 
impact that this gut epithelial cell apoptosis– driven regen-
erative pathology has on the function of the gut mucosal 
barrier cannot be directly determined by studies of fixed 
tissues, barrier dysfunction has been documented in acute 
SIV infection [6], and we also observed additional evidence 
of histopathological changes in the gut, in the neutrophilic 
microabscesses at 28 dpi. As has been recently proposed, 
impaired function of the mucosal barrier could potentially 
contribute to systemic immune activation, through micro-
bial translocation [26, 27], which would help the virus to 
maintain a persistent infection in the gut in 2 ways: (1) by 
providing activated CD4+ T cell targets to sustain infection 
Figure 5. Virus replication and expression of Fas, Fas-L, and tumor-necrosis factor (TNF)–α in gut. Simian immunodeficiency vi-
rus (SIV) RNA+ cells were detected by in situ hybridization using 35S-labeled SIV-specific riboprobes, as described in Materials 
and Methods. In the developed radioautographs, the silver-grain signal from viral RNA imparts a white-yellow appearance to in-
fected cells in reflected epipolarized light. A, SIV RNA+ lamina propria cells and SIV RNA– gut epithelial cells. The double-headed 
arrow indicates 2 clusters of infected cells that are clearly in the lamina propria—i.e., gut epithelial cells are not productively in-
fected. B and C, Immunohistochemical staining for Fas (B) and Fas-L (C), using substrates that impart a brown color to Fas+ cells 
and a red color to Fas-L+ cells. The double-headed arrow in panel B indicates a cluster of Fas+ cells in lamina propria and over-
lying Fas+ gut epithelial cells in the large bowel at the onset of gut epithelial cell apoptosis, and panel C shows that, at that time, 
there are increased numbers of Fas-L+ cells in lamina propria (encircled). D and E, Immunohistochemical staining for TNF-α. D, 
Encircled cluster of brown TNF-α+ cells in lamina propria at the onset of gut infection. As shown in panel E, at peak apoptosis, 14 
dpi, there are no detectable TNF- α+ cells. Original magnifications, ×400.
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and (2) by blunting the SIV-specific CD8+ T cell response in 
the gut [28], perhaps because of a countering immunosup-
pressive T regulatory response, as has been shown for pe-
ripheral lymph nodes [29].
SIV infection may induce gut epithelial cell apoptosis 
by established as well as novel mechanisms whose relative 
contributions will reflect the rapidly changing dynamics of 
infection. At the onset of gut infection, there are rapid in-
creases in lamina propria CD4 T cell apoptosis, which are 
associated with parallel increases in Fas and Fas-L expres-
sion in lamina propria T cells, which we elsewhere have 
proposed as being the mechanism of CD4 T cell apopto-
sis and the major mechanism of CD4 T cell depletion in 
early infection [13]. Here we have shown that there are 
Figure 6. Virion deposition and translocation and shedding of GPR15/Bob. A and D–F, Virus association with GPR15/Bob. Viral 
RNA in virions was detected by in situ hybridization using 35S-labeled simian immunodeficiency virus–specific riboprobes. In the 
developed radioautographs, the silver grains that are the signal from virion RNA have a white-yellow to bluish appearance in re-
flected epipolarized light. A, Background levels of binding in the large bowel of an uninfected animal. D–E, Peak apoptosis. The 
black arrow indicates silver grains in a particulate and diffuse pattern suggesting virion deposition along the basal surfaces of co-
lonic crypts either oriented mainly longitudinally (D) or in cross-section (E). Original magnifications, ×200. F, Jejunal villi. The inset 
(original magnification, ×400) shows a similar pattern of virions deposited at the basal surfaces of 1 of the jejunal villi in the sec-
tion. Original magnification, ×100. B, C, and G–I, Changes in pattern of localization of GPR15/Bob in small and large bowel, as-
sociated with infection and gut epithelial cell apoptosis. GPR15/Bob was stained red, and gut epithelial cells were stained green, 
with fluorophores and, respectively, antibodies to GPR15/Bob and to cytokeratins 5, 6, 8, 17, and 19. Nuclei were counterstained 
blue with TOTO-3, as described in Materials and Methods. Original magnifications, ×600. B, GPR15/Bob before viral replication in 
gut, localizing mainly to basal sides of gut epithelium (encircled) and to mononuclear cells in the lamina propria (small arrow). C, 
Onset of viral replication. GPR15/Bob is still concentrated at the basal side of gut epithelium. G–H, Transcytosis and shedding of 
GPR15/Bob at peak gut epithelial cell apoptosis. G, Vesicles of GPR15/Bob transiting the cell into the lumen. The arrow indicates 
connections between GPR15/Bob in the lumen and an epithelial cell. The staining for cytokeratins reveals intact gut epithelial cells 
below GPR15/Bob in the lumen, showing that luminal GPR15/Bob is not in shed apoptotic cells. H, Sections stained with antibod-
ies and with fluorophores to GPR15/Bob (green) and cleaved cytokeratin 18 (red), as a marker for gut epithelial cell apoptosis. Co-
localizing stains reveal transcytosing GPR15/Bob at the basal (b), middle (m), and top (t) in apoptotic gut epithelial cells. Note that 
GPR15/Bob in the lumen (L) (green arrow) is not also stained with anticleaved cytokeratin 18 and thus is not shed into the lumen 
in apoptotic gut epithelial cells. I, After peak of gut epithelial cell apoptosis. GPR15/Bob is concentrated at the basal and apical 
surfaces of gut epithelial cells, with little evidence of transcytosis and shedding.
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focal increases in Fas expression in intestinal epithelial cells 
(IECs) overlying foci of Fas-L+ lamina propria mononuclear 
cells, such that gut epithelial cell apoptosis may be induced 
by these cells, which elsewhere has been proposed as the 
mechanism of enterocyte apoptosis in celiac disease [17].
Proinflammatory cytokines IFN-γ and TNF-α might also 
play a role in gut epithelial cell apoptosis, as they do in in-
flammatory bowel diseases [18, 19]. In their analysis of cy-
tokinemRNAlevels in tissues from these animals, Abel et. 
al. [20] have shown that there are increased levels of these 
cytokines in the gut as well as in other tissues, and we have 
shown here that there are increased numbers of TNF-α+ 
cells in the lamina propria at a time when IEC apoptosis 
is increasing. However, TNF-α and IFN-γ mRNA levels in 
the jejunum were actually lower than either those in unin-
fected control animals or those in infected animals before 
gut infection [20], so these cytokines cannot account for gut 
epithelial cell apoptosis in both small and large bowel.
Fas and Fas-L and cytokines also cannot be the principal 
mechanism underlying peak gut epithelial cell apoptosis. We 
have shown that there are few Fas-L+ cells in the lamina pro-
pria at 14 dpi, a finding that reflects the massive depletion of 
CD4 T cells by this time. There are also few TNF-α+ cells at 
14 dpi, which is in good agreement with the cytokinemRNA-
data showing decreased mRNA levels at 14 dpi [20].
On the basis of both the observed striking focal depo-
sition of virus and the coincident changes, at the peak of 
gut epithelial cell apoptosis, in the expression and location 
in gut epithelial cellassociated GPR15/Bob-IECs, we specu-
late that peak apoptosis might be the result of virotoxic ef-
fects that virion gp120 has on gut epithelial cells. In a previ-
ous study, such a virotoxic mechanism has been proposed 
to account for both the loss of microtubules and the in-
creased paracellular permeability observed in vitro, which 
were the virotoxic effects of exposing cultured colonic cells 
to HIV-1 gp120 [24]. Because apoptosis was not observed 
in that previous in vitro study, we propose that IEC apop-
tosis in vivo is the result of what we have reported here—
that is, the demonstrable effect that much higher local con-
centrations of virion-associated gp120 has on GPR15/Bob 
expression in gut epithelial cells, an effect that could trig-
ger massive signaling and consequent apoptosis and ob-
served changes in GPR15/Bob. The predisposition of ter-
minally differentiated IECs to undergo apoptosis as they 
near the luminal surface [30] is a necessary second compo-
nent of this speculative model, to explain the restriction of 
apoptosis when virus is deposited at the basal surfaces of 
gut epithelial cells along the villi and crypts (figure 6).
The discovery of gut epithelial cell apoptosis as the un-
derlying mechanism of the regenerative pathology of early 
infection was the result of very close examination of tis-
sues collected [12] in the stunningly fast phase of a slow in-
fection, in which the most dramatic events unfold over a 
period of 7 days. Thus, the power of this highly relevant 
nonhuman primate model of HIV-1 infection is to enable 
studies of pathogenic mechanisms that, by extension, may 
apply to HIV-1 infection in humans but than cannot be 
studied in humans because the time frame in which they 
are most evident precedes the earliest time when HIV-1– 
infected individuals present with the symptoms of acute 
retroviral infection [13, 31–33]. The speed with which SIV 
induces apoptosis of both CD4 T cell populations and the 
intestinal epithelium, with consequent pathological dam-
age to the gut mucosa, attests to the need for new ap-
proaches to early interventions to prevent or greatly mod-
erate the deleterious consequences that infection has on 
adaptive and innate host defenses.
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